Serum miR-663 expression and the diagnostic value in colorectal cancer
Source abstract
Abstract
Colorectal cancer (CRC) is one of the most common digestive cancers leading to deaths worldwide. In this study, we aimed to investigate the diagnostic value of miR-663 in CRC. The expression of miR-663 was detected by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR). The association between miR-663 and clinical parameters of subjects was evaluated by chi-square test. Additionally, ROC (receiver operating characteristic) analysis was performed to evaluate the diagnostic role of miR-663 in CRC. The expression of miR-663 in CRC patients was significantly upregulated compared with benign colorectal disease patients and healthy controls (p < .01). Besides, the expression of miR-663 was significantly associated with tumour differentiation, invasion, lymph node metastasis and TNM stage (p < .05). The cutoff value of miR-663 was 1.31, and the corresponding sensitivity and specificity were 83.1% and 73.8%, respectively. In ROC analysis, the area under the curve (AUC) was 0.806, which indicated that miR-663 could act as an independent diagnostic biomarker for CRC. In conclusion, miR-663 was up-regulated in CRC patients and may be an effective biomarker for CRC diagnosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, the General Hospital of the PLA Rocket Force
Department of Infection Control, Zhuzhou Central Hospital and Affiliated Zhuzhou Hospital of Xiangya Medical College of Central South University
References (31)
Show source-provided references
1. 10.1002/ijc.2551610.1002/ijc.25516 ↗
2. 10.3748/wjg.v13.i28.380610.3748/wjg.v13.i28.3806 ↗
3. 10.1200/JCO.1992.10.6.89610.1200/JCO.1992.10.6.896 ↗
4. 10.1038/mt.2013.2010.1038/mt.2013.20 ↗
5. 10.1101/gad.139980610.1101/gad.1399806 ↗
6. 10.1007/s12032-014-0984-610.1007/s12032-014-0984-6 ↗
7. 10.1007/s12032-014-0934-310.1007/s12032-014-0934-3 ↗
8. 10.1186/1471-2490-14-5010.1186/1471-2490-14-50 ↗
9. 10.1093/nar/gki20010.1093/nar/gki200 ↗
10. 10.1007/s13277-014-2704-410.1007/s13277-014-2704-4 ↗
11. Liu ZY, Zhang GL, Wang MM, et al. MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation. Asian Pac J Cancer Prev. 2011;12:2819–2823.
12. 10.1002/jcp.2451010.1002/jcp.24510 ↗
13. 10.1038/onc.2011.62910.1038/onc.2011.629 ↗
14. Pan J, Hu H, Zhou Z, et al. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep. 2010;24:105–112.
15. 10.1158/1078-0432.CCR-13-228410.1158/1078-0432.CCR-13-2284 ↗
16. Swiderska M, Choromańska B, Dąbrowska E, et al. The diagnostics of colorectal cancer. Contemp Oncol (Pozn). 2014;18:1–6.
17. 10.1016/j.canlet.2013.11.01110.1016/j.canlet.2013.11.011 ↗
18. 10.1038/cr.2008.28210.1038/cr.2008.282 ↗
19. 10.1097/PPO.0b013e318258b78f10.1097/PPO.0b013e318258b78f ↗
20. 10.1186/s13046-014-0113-610.1186/s13046-014-0113-6 ↗
21. 10.1007/s00384-013-1674-010.1007/s00384-013-1674-0 ↗
22. 10.1186/s12935-014-0128-210.1186/s12935-014-0128-2 ↗
23. 10.1007/s00384-012-1461-310.1007/s00384-012-1461-3 ↗
24. 10.1371/journal.pone.004439810.1371/journal.pone.0044398 ↗
25. 10.1002/ijc.2500710.1002/ijc.25007 ↗
26. 10.1186/s40659-019-0219-610.1186/s40659-019-0219-6 ↗
27. 10.1038/s41419-017-0080-x10.1038/s41419-017-0080-x ↗
28. Wang S, Liu J, Li C, et al. Research of the effect of miR-663 on the proliferation of prostate cancer cells, and the correlations of miR-663 with pathological grade and clinical stage. J Buon. 2017;22:1011–1016.
29. 10.3892/mmr.2017.712910.3892/mmr.2017.7129 ↗
30. 10.1074/jbc.M112.43434010.1074/jbc.M112.434340 ↗
31. 10.1093/carcin/bgq14310.1093/carcin/bgq143 ↗